{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:16:09Z","timestamp":1785557769330,"version":"3.56.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,6,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The objective of this study was to assess pregnancy outcome in women with a history of refractory antiphospholipid antibody\u2013associated pregnancy loss(es) who were treated with early low-dose prednisolone in addition to aspirin and heparin. Eighteen women with antiphospholipid antibodies who had refractory pregnancy loss(es) were given prednisolone (10 mg) from the time of their positive pregnancy test to 14 weeks' gestation. Before low-dose prednisolone was given as treatment, 4 (4%) of 97 pregnancies had resulted in live births. Among 23 pregnancies supplemented with prednisolone, 9 women had 14 live births (61%), including 8 uncomplicated pregnancies. The remainder were complicated by preterm delivery, preeclampsia, and\/or small-for-gestational-age infants. There were 8 first-trimester miscarriages and 1 ectopic pregnancy. There were no fetal deaths after 10 weeks' gestation and no evidence of maternal morbidity. The addition of first-trimester low-dose prednisolone to conventional treatment is worthy of further assessment in the management of refractory antiphospholipid antibody\u2013related pregnancy loss(es), although complications remain elevated.<\/jats:p>","DOI":"10.1182\/blood-2011-02-339234","type":"journal-article","created":{"date-parts":[[2011,4,29]],"date-time":"2011-04-29T02:19:31Z","timestamp":1304043571000},"page":"6948-6951","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":157,"title":["First-trimester low-dose prednisolone in refractory antiphospholipid antibody\u2013related pregnancy loss"],"prefix":"10.1182","volume":"117","author":[{"given":"Kate","family":"Bramham","sequence":"first","affiliation":[{"name":"Maternal and Fetal Research Unit, King's College London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Haematology, Guy's and St Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nelson-Piercy","sequence":"additional","affiliation":[{"name":"Obstetric Medicine, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munther","family":"Khamashta","sequence":"additional","affiliation":[{"name":"Lupus Research Unit, King's College London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley J.","family":"Hunt","sequence":"additional","affiliation":[{"name":"Thrombosis and Haemostasis and Lupus Unit, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2019111713193942800_B1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2019111713193942800_B2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2019111713193942800_B3","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/oxfordjournals.humrep.a135907","article-title":"High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies.","volume":"10","author":"Rai","year":"1995","journal-title":"Hum Reprod"},{"issue":"2","key":"2019111713193942800_B4","first-page":"CD002859","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2019111713193942800_B5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.","volume":"36","author":"Laskin","year":"2009","journal-title":"J Rheumatol"},{"issue":"4","key":"2019111713193942800_B6","first-page":"614","article-title":"Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.","volume":"80","author":"Branch","year":"1992","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2019111713193942800_B7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.humrep.a137617","article-title":"Effectiveness of prednisolone\/aspirin therapy for recurrent aborters with antiphospholipid antibody.","volume":"7","author":"Hasegawa","year":"1992","journal-title":"Hum Reprod"},{"issue":"5","key":"2019111713193942800_B8","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","article-title":"Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.","volume":"166","author":"Cowchock","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2019111713193942800_B9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0002-9378(89)90468-7","article-title":"Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody.","volume":"160","author":"Lockshin","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2019111713193942800_B10","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/0002-9378(93)90410-K","article-title":"Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients.","volume":"169","author":"Silver","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2019111713193942800_B11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJM199707173370302","article-title":"Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss.","volume":"337","author":"Laskin","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111713193942800_B12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med"},{"issue":"1","key":"2019111713193942800_B13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0961203309347794","article-title":"Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome.","volume":"19","author":"Bramham","year":"2009","journal-title":"Lupus"},{"issue":"1","key":"2019111713193942800_B14","doi-asserted-by":"crossref","first-page":"IX","DOI":"10.3109\/10641950109152635","article-title":"The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP).","volume":"20","author":"Brown","year":"2001","journal-title":"Hypertens Pregnancy"},{"issue":"2","key":"2019111713193942800_B15","first-page":"131","article-title":"A study of sixty pregnancies in patients with the antiphospholipid syndrome.","volume":"14","author":"Lima","year":"1996","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"2019111713193942800_B16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1538-7836.2005.01185.x","article-title":"Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol.","volume":"3","author":"Stone","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2019111713193942800_B17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9378(11)90692-9","article-title":"Recurrent adverse pregnancy outcome and antiphospholipid antibodies.","volume":"163","author":"Reece","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"9751","key":"2019111713193942800_B18","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome.","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"2019111713193942800_B19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2265.1997.1230939.x","article-title":"Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure.","volume":"46","author":"Benediktsson","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2019111713193942800_B20","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"issue":"2","key":"2019111713193942800_B21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2006.10.879","article-title":"Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies.","volume":"196","author":"Shamonki","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2019111713193942800_B22","first-page":"41","article-title":"Effects of corticosteroids on complement and the neutrophilic polymorphonuclear leukocyte.","volume":"7","author":"Sneiderman","year":"1975","journal-title":"Transplant Proc"},{"issue":"9","key":"2019111713193942800_B23","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/humrep\/14.9.2386","article-title":"Pre-implantation endometrial leukocytes in women with recurrent miscarriage.","volume":"14","author":"Quenby","year":"1999","journal-title":"Hum Reprod"},{"issue":"12","key":"2019111713193942800_B24","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/humrep\/deg502","article-title":"Successful pregnancy outcome following 19 consecutive miscarriages: case report.","volume":"18","author":"Quenby","year":"2003","journal-title":"Hum Reprod"},{"issue":"4\u20135","key":"2019111713193942800_B25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.placenta.2005.04.006","article-title":"The placental bed in pregnancies complicated by primary antiphospholipid syndrome.","volume":"27","author":"Stone","year":"2006","journal-title":"Placenta"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/25\/6948\/1339664\/zh802511006948.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/117\/25\/6948\/1339664\/zh802511006948.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T18:20:02Z","timestamp":1574014802000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/117\/25\/6948\/24351\/Firsttrimester-lowdose-prednisolone-in-refractory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,23]]},"references-count":25,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2011,6,23]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-02-339234","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,23]]}}}